Raymond James Financial
INSM icon

Raymond James Financial’s Insmed INSM Stock Holding History

Raymond James Financial’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.4M Sell
660,601
-114,547
-15% -$13.9M 0.02% 744
2026
Q1 		$121M Sell
775,148
-4,106
-0.5% -$631K 0.04% 441
2025
Q4 		$136M Buy
779,254
+19,276
+3% +$3.52M 0.04% 389
2025
Q3 		$109M Sell
759,978
-24,573
-3% -$3.01M 0.04% 469
2025
Q2 		$79M Buy
784,551
+375,614
+92% +$28.7M 0.03% 561
2025
Q1 		$31.2M Buy
408,937
+45,491
+13% +$3.48M 0.01% 1001
2024
Q4 		$25.1M Buy
+363,446
New +$26.2M 0.01% 1148

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Raymond James Financial's INSM Position: Q2 2026 in Review

Raymond James Financial reduced its Insmed (INSM) stake by 15% in Q2 2026, selling an estimated $13.9M and leaving 660,601 shares worth $70.4M. The position accounts for 0.02% of the portfolio, ranked #744.

Raymond James Financial first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $136M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Raymond James Financial held 660,601 shares of Insmed worth $70.4M as of Q2 2026.
  • Raymond James Financial sold 114,547 Insmed shares in Q2 2026, an estimated $13.9M.
  • Insmed made up 0.02% of Raymond James Financial's portfolio in Q2 2026, its #744 holding.
  • Raymond James Financial first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Insmed position peaked at $136M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.